Suchergebnisse - "Wang, Yan"

PubPharm (5)

1

Rapid and durable response to fifth-line lorlatinib plus olaparib in an ALK -rearranged, BRCA2-mutated metastatic lung adenocarcinoma patient with critical tracheal stenosis : a case report

enthalten in: Anti-cancer drugs | 2022

von Jin, C. | He, Z. | Guo, M. | +5

2

A non-small cell lung cancer (NSCLC) patient harboring a rare epidermal growth factor receptor (EGFR) L858R/V843I mutation complex benefited from osimertinib : a case report

enthalten in: Annals of palliative medicine | 2022

von Zhou, Y. | Qi, X. | Wang, Y. | +2

3

Heterogeneity-based, multiple mechanisms in the resistance to osimertinib (AZD9291) : A case report

enthalten in: Thoracic cancer | 2018

von Liu, Y. | Hao, X. | Hu, X. | +8

4

Concurrent epidermal growth factor receptor T790M secondary mutation and epithelial-mesenchymal transition in a lung adenocarcinoma patient with EGFR-TKI drug resistance

enthalten in: Thoracic cancer | 2017

von Xu, S. | Liu, X. | Liu, R. | +6

5

Response to Crizotinib Observed in Lung Adenocarcinoma with MET Copy Number Gain but without a High-Level MET/CEP7 Ratio, MET Overexpression, or Exon 14 Splicing Mutations

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2016

von Zhang, Y. | Wang, W. | Wang, Y. | +4

1
[1]